Clinical Trial Update: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ritonavir and lopinavir for progressive or recurrent high-grade glioma was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Anaplastic Oligodendroglioma
• Brain Stem Glioma
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma

Drugs mentioned

• Lopinavir (lopinavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Brain Tumor, Anaplastic Astrocytoma | Phase 2 | Status: TERMINATED | Results posted: 2013-06-10